Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001622769-25-000003
Filing Date
2025-10-02
Accepted
2025-10-02 16:16:25
Documents
1
Period of Report
2025-09-30

Document Format Files

Seq Description Document Type Size
1 form4-10022025_081020.html 4  
1 form4-10022025_081020.xml 4 3560
  Complete submission text file 0001622769-25-000003.txt   5102
Mailing Address C/O NEW LEAF VENTURE PARTNERS 7 TIMES SQUARE, SUITE 3502 NEW YORK NY 10036
Business Address
Manke Isaac (Reporting) CIK: 0001622769 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-40315 | Film No.: 251369280

Mailing Address 6707 WINCHESTER CIRCLE, SUITE 400 BOULDER CO 80301
Business Address 6707 WINCHESTER CIRCLE, SUITE 400 BOULDER CO 80301 (720) 307-2892
OnKure Therapeutics, Inc. (Issuer) CIK: 0001637715 (see all company filings)

EIN.: 472309515 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)